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Abstract 
 This study was carried out to determine the indications and 
criteria of patients selection for TURP and to reviews, type of 
anesthesia, hospital stay and whole post operative course 
including the complication in Soba University Hospital (SUH) in 
the period (1999 – 2003). 
     One hundred patients who had undergone TURP in (SUH) in 
the period of the study. All the records were retrospectively 
studied. 
 The mean age was 66.7 years. Duration of symptoms 
range between one week and 20 years with a mean of 2.33 
years. LUTS were observed in all patents. Irrigative symptoms 
were predominate urine retention noted in 40%, while 
haematruia in 19% of the patients. 
 The most important guidelines for patients selection were 
size of the prostate which was small to moderate in most of the 
patients . 
 The most common indications for TURP was LUTS in 
combination with other symptoms in 63%, while LUTS alone was 
the indications in 37% of the patients. 
 Preoperative preparation were done for all patients, with 
pre-anaesthesiatic evaluations. The most common type of 
anesthesia used was regional (spinal or epidural)  
IX 
in (92%) of the patients there were no complications 
observed due to anesthesia. 
 There were no death in the study. Intraoperative 
complications occurred in 5%, immediate post operative 
complication occurred in 13%, and late postoperative 
complications occurred in 33.9%. of the patients. 
 The commonest complications noted were bleeding 
required transfusion in 4%, infection in 6%, TUR syndrome in 
1%, urine retention in 3%, and urethral stricture in 6.4% of 
the patients. 
The catheter was removed within the first  48 hours 
post TURP in most of the patients (59 %). Most of the 
patients discharged from the hospital between 4 – 6 days (56  
%). 
Incidental finding of the prostate reported in a rate of 7% of 
the patients. 
This study showed that TURP accompanied with  very 
Low morbidity and no mortality. Post operative 
catheterization and hospital stay were only few days. So 
TURP remain the golden procedure for treatment of BPH.  
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  ﻣﻠﺨﺺ ﺍﻟﺪﺭﺍﺳﺔ 
  :ﺍﳌﻘﺪﻣﺔ 
ﺘﻌﺩ ﻋﻤﻠﻴﺔ ﺇﺯﺍﻟﺔ ﻏﺩﺓ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﻜﺄﺤﺩ ﺍﻟﺨﻴﺎﺭﺍﺕ 
ﺩ ﺒﺩﺃ ﺘﻁﻭﻴﺭ ﻫﺫﻩ ﺍﻟﻁﺭﻴﻘﺔ ﻭﻗ. ﺍﻟﺠﺭﺍﺤﻴﺔ ﻟﻌﻼﺝ ﺘﻀﺨﻡ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺍﻟﺤﻤﻴﺩ ﻟﺩﻱ ﺍﻟﺫﻜﻭﺭ
ﻡ ﺒﺎﻟﻭﻻﻴﺎﺕ ﺍﻟﻤﺘﺤﺩﺓ ﺍﻷﻤﺭﻴﻜﻴﺔ ﻭﻤﻨﺫ 0391ﻡ ﻭ 0291ﻹﺯﺍﻟﺔ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻤﺎ ﺒﻴﻥ ﺍﻟﻌﺎﻡ 
ﻡ ﻭﺤﺘﻰ ﻴﻭﻤﻨﺎ ﻫﺫﺍ ﺸﻬﺩﻥ ﺼﻨﺎﻋﺔ ﺃﺠﻬﺯﺓ ﻭﻤﻌﺩﺍﺕ ﻤﻨﺎﻅﻴﺭ ﺍﻟﺠﻬﺎﺯ ﺍﻟﺒﻭﻟﻲ 0791ﺍﻟﻌﺎﻡ 
ﺍﻟﺴﻔﻠﻲ ﺘﻁﻭﺭﺍﹰ ﺴﺭﻴﻌﺎﹰ ﻭﻤﻠﺤﻭﻅﺎﹰ ﺤﺘﻰ ﺃﺼﺒﺤﺕ ﺇﺯﺍﻟﺔ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﻤﺠﺭﻱ 
ﻭﺒﺫﺍ ﺼﺎﺭﺕ ﺍﻟﻁﺭﻴﻘﺔ ﺍﻟﻤﺜﻠﻲ ﻟﻠﻌﻼﺝ ﺍﻟﺠﺭﺍﺤﻲ . ﻕ ﻓﻨﻴﺔ ﻭﺘﻘﻨﻴﺔ ﻤﺘﻘﺩﻤﺔﺍﻟﺒﻭل ﺘﺠﺭﻱ ﺒﻁﺭ
ﻜﻤﺎ ﺃﻨﻬﺎ ﺘﺴﺘﺨﺩﻡ ﻓﻲ ﺇﺯﺍﻟﺔ . ﻟﺘﻀﺨﻡ ﻏﺩ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺍﻟﺤﻤﻴﺩ ﻓﻲ ﻜﺜﻴﺭ ﻤﻥ ﺃﻨﺤﺎﺀ ﺍﻟﻌﺎﻟﻡ
  .ﺍﻷﻋﺭﺍﺽ ﺍﻻﻨﺴﺩﺍﺩﻴﻥ ﻓﻲ ﺤﺎﻟﺔ ﺴﺭﻁﺎﻥ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ
  :ﺍﻷﻫﺪﺍﻑ
 ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻟﻤﻌﺭﻓﺔ ﺩﻭﺍﻋﻲ ﺇﺠﺭﺍﺀ ﻭﻤﻌﺎﻴﻴﺭ ﺍﺨﺘﻴﺎﺭ ﺍﻟﻤﺭﻴﺽ ﻟﻌﻤﻠﻴﺔ
ﻭﺍﻴﻀﺎﹰ ﻟﻤﺭﺍﺠﻌﺔ ﻨﻭﻉ ﺍﻟﺘﺨﺩﻴﺭ . ﺇﺯﺍﻟﺔ ﻏﺩﺓ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﻤﻨﻅﺎﺭ ﺍﻟﺒﻭل ﺍﻟﺴﻔﻠﻲ
ﺍﻟﻤﺴﺘﻌﻤل ﻭﻤﺩﺓ ﺍﻟﻤﻜﻭﺙ ﺒﺎﻟﻤﺴﺘﺸﻔﻲ ﻭﻜل ﻤﺴﺎﺭ ﻨﺘﺎﺌﺞ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﺒﻤﺎ ﻓﻴﻬﺎ 
  .ﻭﺫﻟﻙ ﺒﻤﺴﺘﺸﻔﻲ ﺴﻭﺒﺎ ﺍﻟﺠﺎﻤﻌﻲ ﺒﺎﻟﺨﺭﻁﻭﻡ. ﺍﻟﻤﻀﺎﻋﻔﺎﺕ ﻋﻠﻰ ﺍﻟﻤﺩﻯ ﺍﻟﻘﺭﻴﺏ ﻭﺍﻟﺒﻌﻴﺩ
  -:ﻃﺮﻳﻘﺔ ﺍﻟﺒﺤﺚ
ﺠﺭﻴﺕ ﻟﻬﻡ ﻋﻤﻠﻴﺔ ﺇﺯﺍﻟﺔ ﻏﺩﺓ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﺸﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻤﺎﺌﺔ ﻤﺭﻴﺽ ﺃ
. ﻡ 3002ﻡ ﻭﺤﺘﻰ ﺩﻴﺴﻤﺒﺭ 9991ﻁﺭﻴﻕ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﺒﺎﻟﻤﺴﺘﺸﻔﻲ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﻴﻨﺎﻴﺭ 
  .ﻭﺘﻡ ﻤﺭﺍﺠﻌﺔ ﺴﺠﻼﺘﻬﻡ ﻭﺘﺤﻠﻴل ﺍﻟﻤﻌﻠﻭﻤﺎﺕ
  :ﻧﺘﺎﺋﺞ ﺍﻟﺒﺤﺚ
 ﻤﺭﻴﻀﺎﹰ ﻜﻌﻼﺝ ﻟﺘﻀﺨﻡ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺍﻟﺤﻤﻴﺩ ﻭﻟﺜﻼﺜﺔ 79ﺘﻡ ﺇﺠﺭﺍﺀ ﺍﻟﻌﻤﻠﻴﺔ ل
  .  ﺴﺏ ﺴﺭﻁﺎﻥ ﺍﻟﺒﺭﻭﺴﺘﺎﺕﻤﺭﻀﻲ ﻹﺯﺍﻟﺔ ﺍﻷﻋﺭﺍﺽ ﺍﻻﻨﺴﺩﺍﺩﻴﺔ ﺒ
 
 IX
 ﺴﻨﺔ ﻭﺘﺭﺍﻭﺤﺕ ﻓﺘﺭﺓ ﺍﻷﻋﺭﺍﺽ ﻤﻥ ﺃﺴﺒﻭﻉ 7,66ﻜﺎﻥ ﻤﺘﻭﺴﻁ ﺍﻷﻋﻤﺎﺭ ﻟﻠﻤﺭﻀﻲ 
  . ﺴﻨﺔ33,2 ﻋﺎﻤﺎﹰ ﺒﻤﺘﻭﺴﻁ 02ﺍﻟﻰ 
  :ﻭﻗﺩ ﺴﺠﻠﺕ ﺃﻋﺭﺍﺽ ﺍﻟﻤﺠﺭﻯ ﺍﻟﺒﻭﻟﻲ ﺍﻟﺴﻔﻠﻲ ﻓﻲ ﻜل ﺍﻟﻤﺭﻀﻲ ﻭﻫﻲ ﺘﺸﻤل 
 –ﻤﻥ ﺍﻟﻤﺭﻀﻲ % 88ﺍﻷﻋﺭﺍﺽ ﺍﻟﻤﺜﻴﺭﺓ ﻭﺘﺘﻤﺜل ﻓﻲ ﻜﺜﺭﺓ ﺍﻟﺘﺒﻭل ﻭﺴﺠﻠﺕ ﻓﻲ  -1
 ﻭﻗﺩ -%36 ﻭﺍﺴﺘﻌﺠﺎل ﺨﺭﻭﺝ ﺍﻟﺒﻭل ﻓﻲ -% 68ﺒﺤﺭﻗﺎﻥ ﺍﻟﺒﻭل ﻭﺴﺠل ﻓﻲ ﺍﻟﺸﻌﻭﺭ 
  %.13ﻴﺘﺴﺒﺏ ﺍﻻﺴﺘﻌﺠﺎل ﻓﻲ ﺼﻌﻭﺒﺔ ﺍﻟﺤﻜﻡ ﻓﻲ ﺍﻟﺒﻭل ﻭﺴﺠل ﻓﻲ 
 ﺍﻟﺘﻨﻘﻴﻁ ﺒﻌﺩ -%07 ﺍﻷﻋﺭﺍﺽ ﺍﻻﻨﺴﺩﺍﺩﻴﺔ ﺘﺘﻤﺜل ﻓﻲ ﻀﻌﻑ ﺠﺭﻴﺎﺕ ﺍﻟﺒﻭل ﺴﺠل ﻓﻲ  -2
 -% 55 ﺒﻁﺀ ﻓﻲ ﺍﺒﺘﺩﺍﺀ ﺍﻟﺘﺒﻭل ﻭﺴﺠل ﻓﻲ -%75ﺍﻻﻨﺘﻬﺎﺀ ﻤﻥ ﺍﻟﺘﺒﻭل ﻭﺴﺠل ﻓﻲ 
 %.21 ﺠﺭﻴﺎﻥ ﺍﻟﺒﻭل ﻭﺴﺠل ﻓﻲ ﻭﺘﻘﻁﻊ
ﻭﺍﻴﻀﺎﹰ ﻤﻥ . ﻭﻗﺩ ﻏﻠﺒﺕ ﺍﻷﻋﺭﺍﺽ ﺍﻟﻤﺜﻴﺭﺓ ﻋﻠﻰ ﺍﻷﻋﺭﺍﺽ ﺍﻻﻨﺴﺩﺍﺩﻴﺔ ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲ
ﻤﻥ ﺍﻟﻤﺭﻀﻲ ﻭﺨﺭﻭﺝ % 04ﺍﻷﻋﺭﺍﺽ ﺍﻷﺨﺭﻯ ﺍﻷﻗل ﺸﻴﻭﻋﺎﹰ ﺍﺤﺘﺒﺎﺱ ﺍﻟﺒﻭل ﻭﻟﻭﺤﻅ ﻓﻲ 
  %.91ﺍﻟﺒﻭل ﻤﺼﺤﻭﺏ ﺒﺩﻡ ﻭﻟﻭﺤﻅ ﻓﻲ 
ﺍﻟﻤﻭﺠﺎﺕ ﺍﻟﺼﻭﺘﻴﺔ ، ﺕﺘﻡ ﺍﺴﺘﻌﻤﺎل ﺇﺠﺭﺍﺀ ﺍﻟﻔﺤﺹ ﺍﻹﺼﺒﻌﻲ ﻋﻥ ﻁﺭﻴﻕ ﺍﻟﻤﺴﺘﻘﻴﻡ ﻟﻠﺒﺭﻭﺴﺘﺎ
ﻭﺘﺤﺎﻟﻴل ﻭﻅﺎﺌﻑ ﺍﻟﻜﻠﻲ ﻜﺈﺠﺭﺍﺀﺍﺕ ﺘﺸﺨﻴﺼﻴﺔ ، ﻤﻨﻅﺎﺭ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﻭﺍﻟﻤﺜﺎﻨﺔ ، ﺍﻟﺒﻁﻨﻴﺔ 
  .ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲ
  :ﺍﻟﺨﻼﺼﺔ 
ﺃﻭﺠﺩﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺒﺄﻥ ﺃﻫﻡ ﺩﻭﺍﻋﻲ ﺇﺠﺭﺍﺀ ﻋﻤﻠﻴﺔ ﺇﺯﺍﻟﺔ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﻤﺠﺭﻱ ﺍﻟﺒﻭل 
  :ﻜﺎﻨﺕ ( ﺍﻻﺤﻠﻴل )
 –ﻤﺜل ﺍﺤﺘﺒﺎﺱ ﺍﻟﺒﻭل )  ﺃﺨﺭﻱ ﺃﻋﺭﺍﺽ ﺍﻟﻤﺠﺭﻱ ﺍﻟﺒﻭﻟﻲ ﺍﻟﺴﻔﻠﻲ ﻤﺼﺤﻭﺒﺔ ﺒﺩﻭﺍﻋﻲ .1
(  ﻭﻭﺠﻭﺩ ﺤﺼﻭﺓ ﺒﺎﻟﻤﺜﺎﻨﺔ- ﺨﻤﺞ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﺍﻟﻤﺘﻜﺭﺭ-ﺨﺭﻭﺝ ﺍﻟﺒﻭل ﻤﺼﺤﻭﺏ ﺒﺩﻡ
  .ﻤﻥ ﺍﻟﻤﺭﻀﻲ% 36ﻭﻗﺩ ﺴﺠﻠﺕ ﻓﻲ 
ﺃﻫﻡ . ﻤﻥ ﺍﻟﻤﺭﻀﻲ% 73ﺃﻋﺭﺍﺽ ﺍﻟﻤﺠﺭﻱ ﺍﻟﺒﻭﻟﻲ ﺍﻟﺴﻔﻠﻲ ﺒﻤﻔﺭﺩﻫﺎ ﻭﺴﺠﻠﺕ ﻓﻲ  .2
 :ﺍﻟﻤﻌﺎﻴﻴﺭ ﺍﻟﺘﻲ ﺘﻡ ﺒﻬﺎ ﺍﺨﺘﻴﺎﺭ ﺍﻟﻤﺭﻀﻲ ﻜﺎﻨﺕ 
    .ﺍﻭﺡ ﺒﻴﻥ ﺍﻟﺼﻐﻴﺭ ﻭﺍﻟﻤﺘﻭﺴﻁ ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲﺤﺠﻡ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻴﺘﺭ -
 IIIX
ﻅﻬﻭﺭ ﺍﻟﺘﻀﺨﻡ ﻤﺭﺓ ﺃﺨﺭﻱ ﻤﻊ ﺩﻭﺍﻋﻲ ﺇﺯﺍﻟﺘﻪ ﻟﻠﻤﺭﻀﻲ ﺍﻟﺫﻴﻥ ﺃﺠﺭﻴﺕ ﻟﻬﻡ  -
 .ﻋﻤﻠﻴﺔ ﺇﺯﺍﻟﺔ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺴﺎﺒﻘﺎﹰ
ﻋﻼﺝ ﻀﻌﻑ ﺍﻟﺩﻡ ﻭﺍﺴﺘﻘﺭﺍﺭ ﻤﺴﺘﻭﻱ ﺍﻟﻀﻐﻁ ﻭﺍﻟﺴﻜﺭ ﻟﻤﺭﻀﻲ ﺍﻟﻀﻐﻁ ﻭﺍﻟﺴﻜﺭ  -
 .ﻭﻋﻼﺝ ﺍﻟﺘﻬﺎﺏ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﻭﺫﻟﻙ ﻗﺒل ﺍﻟﻌﻤﻠﻴﺔ
ﺘﻡ . ﺒل ﺍﻟﻌﻤﻠﻴﺔ ﻭﺘﻡ ﺘﻘﻴﻴﻡ ﻤﻼﺌﻤﺔ ﺤﺎﻟﺘﻬﻡ ﻟﻠﻌﻤﻠﻴﺔ ﻭﺍﻟﺘﺨﺩﻴﺭﺘﻡ ﺘﺤﻀﻴﺭ ﺍﻟﻤﺭﻀﻲ ﻗ
ﻟﻡ ﺘﻼﺤﻅ ﺃﻱ ﻤﻀﺎﻋﻔﺎﺕ %( 29)ﺍﺴﺘﻌﻤﺎل ﺍﻟﻤﺨﺩﺭ ﺍﻟﻨﺼﻔﻲ ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲ 
  .ﺒﺴﺒﺏ ﺍﻟﺘﺨﺩﻴﺭ
ﻤﻀﺎﻋﻔﺎﺕ ﺃﺜﻨﺎﺀ ﺍﻟﻌﻤﻠﻴﺔ ﺴﺠﻠﺕ ﻤﻌﺩل . ﻟﻡ ﺘﺴﺠل ﺃﻱ ﻭﻓﻴﺎﺕ ﺃﺜﻨﺎﺀ ﻭﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ
 ﺒﻤﻌﺩل ﻤﻀﺎﻋﻔﺎﺕ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻋﻠﻰ ﺍﻟﻤﺩﻯ ﺍﻟﻘﺭﻴﺏ ﺴﺠﻠﺕ، % 5ﺤﺩﻭﺙ 
  %.9,33ﻭﻤﻀﻌﻔﺎﺕ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻋﻠﻰ ﺍﻟﻤﺩﻯ ﺍﻟﺒﻌﻴﺩ ﺴﺠﻠﺕ ﺒﻤﻌﺩل ، %31
  :ﺃﻤﺎ ﺃﻫﻡ ﺍﻟﻤﻀﺎﻋﻔﺎﺕ ﺍﻟﺘﻲ ﺤﺩﺜﺕ ﻓﻜﺎﻨﺕ 
  %.4ﻨﺯﻴﻑ ﺍﺤﺘﺎﺝ ﻟﻨﻘل ﺩﻡ ﺒﻨﺴﺒﺔ  (1
 %6ﺨﻤﺞ ﻤﺎ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻭﻟﻭﺤﻅ ﺒﻨﺴﺒﺔ  (2
 %.1ﺃﻋﺭﺍﺽ ﺯﻴﺎﺩﺓ ﺤﺠﻡ ﺍﻟﺴﻭﺍﺌل ﺒﺎﻟﺩﻡ ﺤﺩﺜﺕ ﺒﻨﺴﺒﺔ  (3
 %.3ﺍﺤﺘﺒﺎﺱ ﺍﻟﺒﻭل ﺒﻨﺴﺒﺔ  (4
 %4,6ﺤﺩﺙ ﺒﻨﺴﺒﺔ ( ﺍﻻﺤﻠﻴل) ﺍﻟﻤﺩﻯ ﺍﻟﺒﻌﻴﺩ ﻀﻴﻕ ﻤﺠﺭﻱ ﺍﻟﺒﻭل ﻭﻋﻠﻰ (5
ﺘﻡ ﺇﺯﺍﻟﺔ ﺍﻟﻘﺴﻁﺭﺓ ﺍﻟﺒﻭﻟﻴﺔ ﺨﻼل ﺍﻟﻴﻭﻤﻴﻥ ﺍﻷﻭﺍﺌل ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻓﻲ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲ 
 4ﻭﻜﻤﺎ ﺘﻡ ﺨﺭﻭﺝ ﻤﻌﻅﻡ ﺍﻟﻤﺭﻀﻲ ﻤﻥ ﺍﻟﻤﺴﺘﺸﻔﻲ ﻓﻲ ﻓﺘﺭﺓ ﺘﺘﺭﺍﻭﺡ ﺒﻴﻥ %( 95)
  %(.65) ﺃﻴﺎﻡ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ 6ﺍﻟﻰ  
ﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﺍﻟﻤﺼﺎﺩﻓﺔ ﺒﻤﺭﻀﻲ ﺘﻀﺨﻡ ﺘﻡ ﺘﺴﺠﻴل ﻭﺠﻭﺩ ﺴﺭﻁﺎﻥ ﺍﻟﺒﺭﻭﺴ
  %.7ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺍﻟﺤﻤﻴﺩ ﺒﻤﻌﺩل 
 IIIX
ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺒﻴﻨﺕ ﺃﻥ ﻤﻀﺎﻋﻔﺎﺕ ﻋﻤﻠﻴﺔ ﺇﺯﺍﻟﺔ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﻋﻥ ﻁﺭﻴﻕ ﺍﻟﻤﻨﻅﺎﺭ ﻗﻠﻴﻠﺔ 
ﻜﻤﺎ ﺃﻥ ﻤﺩﺓ ﺘﺜﺒﻴﺕ ﺍﻟﻘﺴﻁﺭﺓ ﺒﻌﺩ ﺍﻟﻌﻤﻠﻴﺔ ﻭﺍﻟﻤﻜﻭﺙ . ﺠﺩﺍﹰ ﻜﻤﺎ ﺍﻨﻪ ﻻ ﻴﻭﺠﺩ ﻭﻓﻴﺎﺕ 
ﻌﻤﻠﻴﺔ ﻤﺎﺯﺍﻟﺕ ﻫﻰ ﻭﻫﺫﺍ ﻴﻭﻀﺢ ﺃﻥ ﻫﺫﻩ ﺍﻟ، ﺒﺎﻟﻤﺴﺘﺸﻔﻲ ﻻ ﻴﺘﻌﺩﻱ ﺃﻴﺎﻡ ﻗﻼﺌل 
 . ﺍﻟﻁﺭﻴﻘﺔ ﺍﻟﻤﺜﻠﻲ ﻟﻌﻼﺝ ﺘﻀﺨﻡ ﺍﻟﺒﺭﻭﺴﺘﺎﺕ ﺍﻟﺤﻤﻴﺩ
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BACKGROUND 
The Department of urology in Soba hospital was established in 1975 
with the opening of Soba University hospital. 
 Few months following this endourology unit was established. 
The first transurethral resection of the prostate  
(TURP) was performed in Soba University hospital in 1975. At the 
beginning there were no anaesthestic facilities in the cystoscopy 
room, and all the procedures with general or regional anesthesia 
were performed in the main theater complex, moving all the scopes to 
the main theatere.  
In the early days the number of TURP performed in Soba 
University Hospital was limited, because the available operating time 
was limited in the main theater complex. 
In the year 1991 the endourology unit was supplied with 
anaesthestic   machines and an anesthiologist, since that time the 
number of TURP done showed a considerable increase. 
In the year 2001, and with great efforts of Professor Sharfi, Mr. 
Sief ELdin Mohamed. Nour, and the administration in Soba university 
hospital, rehabilitation and extension in the department of urolog  
 took place. By the and of the year 2003 a new theatre room for open 
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 surgery was established, followed by introduction of an urocam 
video camera for endourology, appointing paramedical staff and the 
rest of the armamentarium needed for the department.  
This renovation in the department of urology with increase in 
the number of consultant urologists, during the last three years, 
promoted the quality and quantity of procedures. That was clearly 
reflected by two to three folds increase in the number of TURP 
performed   in the last two years(1). 
The figure below shows the total number of prostatectomy done 
within the period (1999-2003) with comparison between open and 
transurethral prostatectomy (3). 
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 Open prostatectomy fluctuating in frequency. 
               TURP Took step ladder manner. 
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INTRODUCTION 
 
Benign prostatic Hyperplasia (BPH) and prostate 
adenocarcinoma are the two major neoplasms affecting the human 
prostate. Together these two diseases constitute a major proportion 
of pathologies affecting the urological system (3). 
Benign prostatic Hyperplasia (BPH) is seldom life threatening.  
It can have a significant impact on aging males’ quality of life. In the 
majority of men affected, the disease produces urinary symptoms that 
are slightly inconvenient in some patients, and it could be more 
bothersome in others or with development of serious sequel, that may 
necessitate therapeutic intervention. 
 The treatment of this condition should be preceded by good 
evaluation, assessment of symptoms and signs, proper 
investigations, and to find out any complications so as to select the 
appropriate type of treatment.  
Transurethral resection of the prostate (TURP) is the most 
common surgical procedure for treatment of  benign prostatic 
hyperplasia in USA,  and it is clearly the most effective treatment of  
BPH(4).  The TURP  procedure can also be used as palliative method 
for ca prostate with obstructive symptoms(3). 
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  TURP is a popular procedure nowadays with high utilization in 
wide area in the world(5).   Many comparative studies have been done 
for the procedure versus other surgical modalities (Open 
prostatectomy or other transurethral minimal invasive procedures) 
showed that TURP remains the surgical standard to which other 
interventional therapies are compared (6). 
In the Sudan there are two studies which looked into the 
management of Benign prostatic Hyperplasia: In the year 1998 
Baoum and in 2002 Khalafalla A(7,8). They found that TURP 
procedure was accompanied by the least complications and short 
hospital stay.    
Indications for prostatectomy:-  
Indications for prostatectomy depend on many factors:-   
1- In Large adenomas retropubic prostatectomy is preferred.  
2- Moderate sized adenomas can be removed by TURP or open 
methods. The choice between the two methods depends upon the 
surgeon’s preference and his skill to perform transurethral 
resection.  
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3- Transurethral  resection of the prostate (TURP) is indicted in :- 
- Small and moderate size enlarged prostate.  
 - Glands diagnosed clinically as fibrosed from previous prostitis. 
 - Obstructing prostatic carcinoma (9,10). 
 Transurethral resection of the prostate started in the Urology 
Unit of Soba University Hospital more than twenty years ago.  
Since  that time no critical review was carried to evaluate this 
procedure.    
This study reviews the indications for TURP, type of the 
anesthesia, the hospital stay and its complications.     
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 ANATOMY OF THE PROSTATE 
 
The normal prostate is about 18 gm and its measurers about 3 cm 
in length, 4cm in width and 2cm in depth. 
 Although it is ovoid in shape, the prostate is referred as having 
anterior, posterior and lateral surfaces with a narrowed apex inferiorly 
and broad base superiorly that it continues with the base of the 
bladder. 
The prostate is traversed by the prostatic urethra. The apex of the 
prostate is continuous with striated urethral sphincter. 
Anatomical Relations: -  
The prostate gland is enclosed by a capsule composed of 
collagen elastin and abundant smooth muscles. Posteriorly and 
laterally this capsule has an average thickness of 0.5 mm. On the 
anterior and anteriolateral surface of the prostate the capsule blends 
with the visceral continuation of endopelvic fascia.  
Towards the apex the puboprostatic ligament extends anteriorly to 
fix the prostate to the pubic bone. 
Laterally the prostate is cradled by the pubococcygeal portion of 
the levator ani muscle and is directly related to its overlying 
7 
endopelvic fascia. Posteriorly, loose areolar tissue defines a thin 
plane between denonvillier’s fascia and the rectum.  
Structure and histology:- 
The prostate is composed of approximately 70% glandular 
elements and 30% fibromuscular stroma. 
The urethra runs the length of the prostate and is usually 
closest to its anterior surface. It is lined by transitional epithelium 
which my extend into the prostatic duct. 
A urethral crest projects inward from the posterior midline, runs 
the length of the prostatic urethra and disappears at the striated 
sphincter.  On either side of the crest a groove is formed into which 
all glandular elements drain at its mid point. The urethra turns 
approximately 35 degrees. This angulations may vary from zero to 90 
degrees.  This angle divides the prostatic urethra into proximal and 
distal segments which are anatomically and functionally discrete. 
 In the proximal segment the circular smooth muscle thickens to 
form the involuntary internal unearthly sphincter per urethral glands at 
this area incriminated as one of the sites of origin of BPH.  Beyond 
the urethral angle all major glandular elements of the prostate open 
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 into the prostates urethra.  The urethral crest widens and protrudes 
as the verumontanum.  
A small slit like orifice of the prostatic utricles is found at the 
apex of the veru. To either side of the utricles two small openings of 
ejaculatory duct may be found. The ejaculatory ducts are formed at 
the junction of the vas defrans and seminal vesicles.     It runs nearly 
2 cm through the prostate in line with the distal prostatic urethra. 
Zonal anatomy of the prostate:-         
The glandular elements of the prostate have been divided into 
three zones, distinguished by the location of their ducts in the urethra 
by their differing pathologies and in some cases by their embryologic 
origin. 
Transition Zone:- The duct arises at the angle dividing the 
preprostatic urethra and prostatic urethra. It passes beneath the 
prostatic sphincter to travel on its lateral and posterior sides.  It 
comprises 5% to 10% of the glandular tissue.  The transition zone 
commonly gives rise to BPH. It is estimated that 20% of 
adenocarcinomas of the prostate originate in this zone. 
Central Zone:-  At this zone the ducts arise circumferentially around 
the opening of the ejaculatory ducts. This zone constitutes 25% of the 
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glandular tissue and only 1% to 5% of adenocacinomas arise at the 
central zone.  
Peripheral Zone:- makes up the bulk of the prostatic glandular tissue 
(70%) and covers the posterior and lateral aspects of the gland.  Its 
ducts drain in the prostatic sinus along the entire length of the 
prostatic urethra. Seventy percent of prostatic cancers arise in this 
zone. 
Clinically The prostate is often spoken of as having two lateral lobes, 
separated by central sulcus palpable on rectal examination and a 
middle lobe, which may project into the bladder in older men. 
Blood supply:- The arterial supply of the prostate arises from the 
inferior vesicle artery.  It divides into two main branches:-  
1. Urethral artery which supply the urethra, periurethral glands 
and the transition zone. Thus in BPH,  these arteries provide 
the principal blood supply of the adenoma.  When this gland is 
resected or enucleated, the most significant bleeding is 
commonly encountered at the bladder neck particularly at the 4 
and 8-o’clock position. 
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2. The capsular artery is the second main branch and it gives 
capsular branches. These branches pierce the capsule to 
supply the glandular tissue. 
Venous and lymphatic drainage:-  
Venous drainage is abundant through the peri-prostatic plexus.  
Lymphatic drainage is primarily to the obturator and internal iliac 
nodes.  A small portion may initially pass through the presacral group 
or less commonly, the external iliac nodes. 
Nerve Supply:-  
Sympathetic and parasympathetic innervation from the pelvic 
plexus travels to the prostate through the cavernous nerve(11). 
 
PHYSIOLOGY OF THE PROSTATE 
 
 
  The prostate has a sexual function, but it is a little unclear how 
important its secretions are to human fertility. 
Growth of the prostate and hormonal influence:-   
The growth of the prostate is governed by many local and 
systemic hormones. 
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 The main hormone acting on the prostate is testosterone which 
is secreted by the ledge cells of the testes under the control of 
anterior pituitary. Testosterone is converted to 5-de- 
hydrotestosterone (DHT) by the enzyme 5-hydroxy - reductase which 
is found in high concentration in the prostate and the perigenital skin. 
 Other locally acting peptides are secreted by the prostatic 
epithelium and mesenchymal stromal cell in response to steroid 
hormones. These peptides undoubtedly play part in normal and 
abnormal prostatic growth, but yet their functions are unclear. 
Elaboration and secretion of prostate-specific antigen (PSA) and 
acid phosphatase:- 
 PSA is a glycoprotein. Its function may be to facilitate 
liquefaction of the semen and it is marker for prostatic disease  
PSA measurement has superseded measurement of serum acid 
phosphatase(12).  
BENIGN PROSTATIC HYPERPLASIA (BPH) 
Etiology of BPH: 
 BPH is a disease of aging males.   Its Incidence increased with 
age.  Normal androgen hormone status also is etiological risk factor.  
The disease is not seen in men below 20 years and castrated 
males before puberty.    
 
12 
  The precise etiology is uncertain.   Increase in the number of 
the cells may be to epithelial and stromal cell proliferation or 
impaired programmed cell death. 
Hormonal factors:- 
Androgen, estrogens, growth factors, and some neuropeptides 
may play a role singly or in combination (13). 
 The initiation of BPH may not be environmental or genetically 
influenced. The prevalence of microscopic BPH increases with age in 
all male population and that all men will develop BPH if they live long 
enough(3). 
Pathology of BPH:- 
 The earliest change of BPH occurs in the periurethral gland 
around the verumontanum. 
Hyperplasic changes may result in stromal nodules, acinar 
nodule or mixed fibroadenomatous nodules. 
  The stromal nodules are composed of varying amounts of 
fibrous and smooth muscle cells and may be infiltrated by 
lymphocytes. 
  Fibromuscular nodules contain varying amounts, of fibrous 
tissue admixed with glandular hyperplasia. 
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  Glandular hyperplasia may occur as predominantly acinar 
nodule or mixed with stromal hyperplasia. 
 The glands are often large with unfolding acini composed of tall 
columnar cells(3). 
Clinical picture:- 
 Benign prostatic hyperplasia (BPH) occurs in many men around 
or above the fifth decade of their age.  Symptoms known as lower 
urinary tract symptoms (LUTS) are either obstructive or irritative.    
Obstructive symptoms includes:- 
• Hesitancy        
• Poor stream    
• Intermittent stream                                     
• Dribbling       
• Sensation of poor bladder emptying     
• Episodes of near retention.   
Irritative symptoms includes:- 
•  Increased Frequency 
• Nocturia 
• Urgency 
• Urge incontinence 
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• Nocturnal incontinence(12) 
 These symptoms are not specific for BPH. They may occur with 
some others lower urinary tract disorders. Many scoring systems 
were developed to assess the severity of LUTS.  International 
prostate symptoms score (I.PSS), which was developed by the 
American Urological Association (AUA). In patients with BPH this 
scoring system is used to help in selection of suitable type of 
treatment(4,14,15). However some symptoms may not reflect the 
underlying problem accurately.  
BPH can give rise to haematuria; in this case other causes of 
haematuria should be excluded(12). 
Rectal examination:- 
   Digital rectal examination DRE provides sufficiently accurate 
estimations of the sizes and feeling of the prostate in most cases. 
However the size of the prostate should not be the only decisive 
factor in considering whether active treatment is required.  Prostate 
size does not correlate with symptoms severity, degree of 
urodynamic obstruction or treatment outcome(13). 
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Investigations: -  
 There are some important investigations for patients with 
enlarged prostate. These investigations are to confirm the diagnosis 
and assess the degree of urinary obstruction, complications due to 
long standing obstruction and to answer important points about the 
patient’s condition which can lead to selection of suitable type of 
treatment. These are:-  
1- Urinalysis:-  to role out the presence of infection and/or 
haematuria.  Haematuria is a cause for a work-up for other 
conditions. 
2- Blood urea and electrolyte: - provide baseline information about 
renal functions. 
3- Ultrasonography:- In BPH ultrasonography (U/S) is very useful in 
measuring bladder and prostate volume as well as measuring 
residual urine.  Estimation of bladder and prostate volume with US 
is in the accuracy range of 80-87%.  U/S also detects bladder 
calculi, diverticula, large bladder tumour and other obvious bladder 
pathology. 
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4- Transrectal ultrasongraphy (TRUS): It is a useful procedure in 
estimation of sizes of the prostate and increases the detection rate 
of ca prostate up to about 60%.  TRUS guided biopsy of the 
prostate is more accurate than digital guidance(3,16,17).  
5- Urethrocystoscopy:-  When need for surgery has been 
determined, cystoscopy is useful for several reasons:- 
1. The position of the ureteral orifices may be noted to 
prevent inadvertent injury. 
2. Assessment of bladder capacity, bladder trabiculations 
and diverticula. 
3. Occasionally, bladder calculi and small bladder tumour 
not recognized by preoperative U/S evaluation may be 
noted(3). 
6- Prostate specific antigen ( PSA):- PSA has been in wide-spread 
clinical use since 1987.  Since that time, PSA has been used as a 
marker to measure recurrence after therapy and more recently as 
a marker for early detection of the prostate cancer. 
The normal level of serum PSA is 4 ng/ml or less.   
     From 4.1–10 ng/ml is mild elevation but can not role out    
      malignancy    
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From 10 to 20 ng/ml is suspicious.  
If serum PSA  More than 20 ng/ml prostatic biopsy should be 
taken , regardless of the DRE; this can give 65% cancer detection 
rate.   
It is recommended that PSA measurement should be delayed 
for four to six weeks after TURP, or prostatic biopsy due to the 
expected elevation of PSA after these procedures(18).    
7- Transrectal biopsy of the prostate:- The most common  
indication for prostatic biopsy in a palpable  prostatic nodule is 
to role out the possibility of adenocarcinoma.  When suspicious 
findings detected by digital rectal examination (DRE) or by 
elevation of PSA (normal value < 4 ng/ml) biopsies are required 
to exclude carcinoma(19). 
8- Urodynamic:- Use of urodynamics in the diagnoses of BPH is 
still controversery(20). 
In BPH urodynamics were considered in many studies as one 
of the tools of preoperative evaluation and post operative follow-up.    
Urodynamics based on low flow rate with high voiding pressure 
flow rate <10 ml/second for void volume more that 200ml, will be 
sufficient   for most urologist to recommend treatment (21, 22, 23). 
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 CARCINOMA OF THE PROSTATE  
 
Etiology:-  
 Ca prostate also is a disease of ageing men and it rarely occurs 
in men below 40 years of age. Etiology of ca prostate based upon 
epidemiological observation, at least four factors has been cited as 
possibly etiological in prostate cancer. These include genetic 
predisposition, hormonal influences, dietary and environmental 
factors and infectious agents(3).  
Treatment of ca prostate:-   
     In early carcinoma of the prostate which is suspected by finding of 
prostatic nodules in digital rectal examination, the diagnosis has been 
improved by measuring PSA level, transrectal ultrasound and 
transrectal biopsy(17,24,25).  Radical prostatectomy gives good chance 
for cure in early diagnosis. 
 In advanced cases of prostatic carcinoma with severe 
obstructive symptoms, acute urine retention and evidence of distant 
metastasis, TURP may be combined with orchidectomy or other 
hormonal therapy to prevent further progression of symptoms(3). 
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TRANSURETHRAL   PROSTATECTOMY 
History: - 
 Transurethral prostatectomy was developed in United State in 
the 1920s and 1930s. Nesbit (1975) pointed out that there were 
several significant factors important in its development. 
The invention of incandescent lamp by Edison in 1879.  The 
cystoscope development independently by Nitze and Lietr in 1887.  
The development of the fenestrated tube by Hugh Hampton Young 
which allowed the obstructing tissue to be sheared off blindly. Other 
important factors: In 1908 invention of the vacuum tube by Deforest 
that allowed the constant production of high-frequency electric current 
that could be used in resecting tissue.  In 1926 Bumpus combined the 
cystoscope and the tubular punch.  Also at that time, Streans 
developed the Tungsten loop that could be useful for resection.  This 
was put together by Mccarthy in 1932 using a Forobligue lens so that 
could resects the tissue under direct vision using a wire loop.  In the 
1970s the development of fibroptic lighting system, together with the 
Hopking (1976) rod lens wide angle systems significantly improved 
visualization for endoscopic surgery. 
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Over the years, transurethral  resection of the prostate TURP, 
as treatment modality for obstructing benign prostatic hyperplasia 
BPH, gained popularity throughout the world(5).   It is now considered 
the golden standard for surgical management of BPH.      
Resectoscope:- 
 A resectoscope sheath with its obturator, size 26 E or 24 E 
once sheath has passed into the bladder, the obturator is removed 
and replaced by the working elements of resectoscope, which has a 
channel for the fore-oblique or direct view telescope (a 0 or 120 or 30 
depending upon the make of the instrument) and one for the loop 
electrode. 
Deferent working elements, have different mechanism for 
moving the loop backwards and forwards, but most are now one 
handed.  Cutting loops vary in size and are colour coded. 
 The larger the loop, the larger the chips of prostate that can be 
cut, but the surgeon should select the suitable size of the loop which 
can pass easily without damaging the urethra. 
The loop consists of cutting wire, supported on an insulated 
stem by an insulated fork, which often incorporates a stabilizing 
device. The proximal end of the loop fit into insulated block of the 
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working elements, which attached to diathermy machine by the 
diathermy cable. The tap on the resectoscope sheath is connected 
to the source of the irrigating fluid, which is usually in plastic 
containers. 
Irrigation and irrigants:- 
The working element has to be removed from the sheath at 
regular intervals to empty the bladder.   Cystoscope with continuous 
irrigation is available now. The irrigant fluid should be isotonic or 
near isotonic. The available one is glycine 1.5%.  Sterile normal 
saline should not be used during the resection because it is 
electroconductive and may disturb the electrocuting coagulation 
current(26).  Relative safety of distilled water as an irrigation fluid for 
TURP under continues drainage has been reported by some 
authors(27.28).     
Indications for TURP:- 
 In BPH the most common reason that intervention is 
recommended in a patient with symptoms of bladder outlet  
obstruction and irritability, that the symptoms  are moderate to severe, 
bothersome and interfere with the patient’s  quality of life(5). 
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 The American Urologist Association (AUA) in a recent survey of 
4000 cases found that the most common indication for transurethral 
prostatectomy include symptoms of prostatism in 90% of the patients, 
prostatism with residual urine in 15%, prostatism with acute urine 
retention 9.6% and combination of all three is 5.6%.  Other operative 
indications reported were recurrent UTI in 12%, haematuria in 12%, 
renal insufficiency in 4.5% and bladder stone in 3%(3).  
Preoperative preparation for TURP:- 
  All those patients above forty years so apart of  urological  
work-up, complete blood count, chest x-ray, ECG, blood urea, 
electrolyte and creatinine, urine for sugar and acetone are required. 
On admission a formal signed  consent should be obtained, blood 
grouping with preparation of two  units of blood and good 
preoperative anaesthetic assessment should be done.  Patients must 
be fasting six hours before the procedure(3,29). 
Anaesthesia :- 
  Transurethral surgery of prostate is usually performed under 
general, spinal or epidural  anaesthesia(30).  Regional  versus general 
anaesthesia has been  evaluated.  The results revealed that no 
deference in blood loss and postoperative morbidity or mortality(31). 
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Preoperative Antibiotic: - 
Urinary tract infection can be found in 8% to 24% of BPH 
patients preoperatively. The infection should be treated prior to 
surgery.  
The use of prophylactic antibiotics in TURP is somewhat 
controversial. It is recommended that the patients should be given 
systemic antibiotic prior to initiation of surgery and then maintain the 
patients on oral antibiotic for five days after catheter removal(5). 
 
SURGICAL TECHNIQUE OF TRANSURETHRAL RESECTION OF 
THE PROSTATE (TURP) 
 
TURP should be done in a theatre, where transurethral or open 
prostatectomy can be done, with preparation of  two units of blood 
which would have rarely been used. 
Position on table: -   
Patient placed in the appropriate position for cystoscopy.  Avoid 
excessive flexion of hip and knees and make sure that the legs rest,  
but no strain on hip and knees. Clean the skin of the penis and 
scrotum with sterile betadine and put on sterile drapes. The penis 
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brought through a hole in the center of the  sheet.  Below this hole is 
a finger cot  which is lubricated and inserted into the rectum.  This will 
help the surgeon to examine the prostate through the rectum without 
becoming unsterile. 
Cystourethroscopy :-   
After filling the urethra with lubricant then start with calibration 
of the urethra, then with cystourethroscope, look for any abnormality 
like urethral stricture which my need internal urethrotomy (DVIU). 
Look for blabber tumour, stone, or diverticula and then look for 
ureteral orifices,  trigone and bladder neck. Then determine the land 
marks, neck of bladder, verumontanum and the external sphincter 
muscle. 
Assessment of prostates size:-  
The assessment of prostates size is made partly by endoscopy 
and partly by bimanual examination, which is best  done while the 
cystoscope is in the bladder(26). 
Technique:-   
Various techniques have been suggested for systematic 
removal of the adenomatous tissue. They  all are based on the 
principle that the resection should be done step by step, i.e:- 
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The Nestbit surgical technique has three stages. 
First stage:- The fibers at the bladder neck and those of the 
immediately adjacent prostatic adenoma are resected with short, full- 
thickness bites circumferentially around the bladder neck. This 
process starts at the 12 o’clock position and then carried out on either 
side until finally the bladder neck tissue between 5 and 7 o’clock is 
resected in this manner. 
The second stage:-  The adenoma resected in quadrants. The 
resectoscope is placed in front of the veru and the resection started 
at 12 O’clock position. The upper quadrants on both right  and left 
side are resected first down to the fibers of the surgical capsule, then 
the lower quadrants resected down to the surgical capsule. 
Surgical capsule can be identified by a number of hall marks.  
For example, the yellowish, nodular tissue of adenoma changes to 
the white glistening surface of the compressed peripheral zone of the 
prostate or surgical capsule. 
At the third stage:- The adenomatous tissue surrounding the 
verumontanum is resected last.  After completing the resection of all 
adenomatous tissues down to the surgical capsule circumferentially, 
an incision of the bladder neck my be performed as recommended by 
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Kulb et al to prevent bladder neck contracture specially in a patient 
with a small prostate. 
The introduction of constant-flow resectoscope facilitate the 
procedure by allowing continuous resection, clear vision and low 
pressure within the prostatic fossa, with decreased fluid absorption 
and shortened surgical time.  
During the operation, the accumulation of the chips of the 
prostate and blood clot, which makes unclear vision, should be 
removed with Elik evacuator. Haemostasis should be achieved 
perfectly throughout the procedure and after completion of the 
resection, particularly around the bladder neck  where small bleeders 
are often seen(30). 
  Some important points must be considered during the 
procedure:- 
1. Do not resect below the verumontanum or above bladder 
neck. 
2. Hold the resectoscope sheath still while resecting to be 
sure, only the loop moves and cutting done under vision. 
3. Achieve haemostasis after each cut or at least before 
digging another trench. 
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4. Do not cut unless you can see clearly; abandon the 
procedure if you can not(26). 
A 24 Fr, three-way Foley catheter inserted. It is not 
recommended to inflate the balloon in prostatic fossa. The 
balloon inflated with approximately 30 ml of suitable fluid. 
Continuous or intermittent irrigation started. Irrigation is 
stopped once the washing fluid is clear. On the first or 
second postoperative day catheter may be removed (24-48 
hours)(26,30). 
 
COMPLICATIONS OF  TURP. 
 
 Complications of TURP can occur intraopertively, immediate 
postoperative or as late outcome.  These include:- 
1. Perforation:-  
 Perforation of the prostatic capsule or bladder can occur 
interaoperative. This may be as a result of inexperience in 
association with a large prostate or heavy blood loss.  If the vision 
obscured due to heavy bleeding, better to achieve good haemostasis 
abandon the procedure and insert a urethral catheter. Suprapubic 
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space drainage may be needed. If any suspicion of intraperitoneal 
extravasation, the peritoneum should be opened(12,26). 
2. Bleeding:-  
 Bleeding is a major risk following prostatectomy some times 
requires blood transfusion. In TURP care should be taken, bleeders 
must accurately stop with diathermy. Patients should be warned 
about secondary bleeding that may occur after discharge. If patient 
came back with clot retention, reinsert catherter wash the bladder , 
and observe the patient for bleeding. To refer the patient to theatre is 
rarely needed(12). 
3.  Transurethral Resection syndrome (TUR syndrome):-  
This complication can result from entrance of irrigant fluid to the 
vascular compartment. Type of irrigant should be isotonic or near 
isotonic (glycine 1.5%). Risk of TUR syndrome increase with 
prolonged resection time (more than 90 minutes), large prostate and 
perforation of prostatic capsule or bladder.  
The syndrome is characterized by increase of intravascular 
fluid, which may lead to hypervolaemia, hyponatraemia haemolysis. 
nausea, vomiting, hypertension, bradycardia, visual disturbance, 
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convulsions and coma may occur.  Usually symptoms do not appear 
until serum sodium reaches (125 mEq). 
Treatment should start promptly with close monitoring for vital 
signs cardiac status and urine output. Serum electrolyte must be 
followed closely. Hypervolaemia and hyponatraemia should be 
corrected by giving the patients 200 ml of 3% saline very slowly over 
a period of time and diuretic (furosemide)   
The American Urologist Association (AUA), in a cooperative 
study, found that TUR syndrome occurred in 2% of patients who 
underwent TURP (5). 
 4. Clot retention:- 
This is one of the serious immediate complications of any type 
of prostatectomy  and  occur  when  blood  colt  block the catheter.   It   
rarely   occur  while  the  bladder is  irrigated  through a three  ways   
catheter.   Milking  the  catheter  or  using bladder syringe can clear   
small clots.  If  these measures are unsuccessful, the patient should 
be taken to the theater and a large bore catheter or resectoscope 
sheath passed through urethra under general anesthesia to allow 
evacuation of the clot by vigorous irrigation with Wardill’s all- glass or 
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Elik evacuator . If even this failed, the bladder must be opened or 
reopened, although that is rarely necessary .              
 5. Urine incontinence:- 
Some patients have stress or urge incontinence for some days  
after operation. Incontinence is uncommon unless the external 
sphincter has been damaged and this should not happen.  By taking 
care, resection should not extent beyond verumontanum. In some 
patient incontinence occur due to some residual apical tissue, 
continence may restore with resection of this tissue(26). 
6. Infection:-  
Bactraemia may occur after TURP. Antibiotics as prophylaxis 
with induction of anesthesia and for few days after the procedure, 
reduce the incidence of bactreamia. Postoperative urinary tract 
infection may occur if the catheter remains more than one week. If 
the catheter remained for a long time, culture may be needed after 
removal of the catheter to treat the residual infection.  Epididymitis is 
so rare after TURP(10) 
7.  Urethral stricture:  
  It may be due to prolonged catheterization, unnecessarily big 
catheters and/or clumsy instrumentation. It can occur just inside the 
 
 
 
31 
meatus or in the bulbar urethra. Early stricture can be managed with 
simple bouginage, but later on,  it may need urethrotomy.  
8.   Bladder neck contracture:- 
  Occasionally occur as a dense fibrotic stenosis of bladder neck 
as a result of over aggressive resection of small prostate, or 
diathermy overuse. Transurethral incision of the scar tissue is 
necessary (12). 
9.  Retrograde ejaculation:- 
This complication is less common with TURP than other form of 
prostatectomy.   This possibility should be explained to the patient. 
10.  Impotence:-  
The relation of this complication to TURP is unclear but it may 
be element of depression. The surgeon should discuss the matter 
with the patient(10). 
ASSOCIATION OF BPH AND PROSTATIC CANCER 
There are a number of similarities between BPH and prostatic 
cancer:- 
• Both increase in prevalence with age. 
• Both require androgens for growth and development. 
• Both respond to androgens deprivation treatment. 
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Most cancer arises in prostate with concomitant BPH and 
cancer of the prostate is found incidentally in a significant number 
(10%) of TURP specimen.  Inspite of that, BPH is not a 
premalignant lesion nor a precursor(32). 
 
HOSPITAL STAY AND CATHETER REMOVAL 
 
 Early catheter removal reduces hospital stay.  Removal of the 
catheter within 24 hours, and discharge in 24 to 48 hours after TURP 
is reasonable and a safe goal for most patients(33). 
Alternatively early hospital discharge with catheter in place is a 
reasonable postoperative management strategy when earlier catheter 
removal is not appropriate(34).       
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Chapter Two 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OPJECTIVES 
 
1. To determine the indications for TURP in Soba University  
hospital within the last 5years   
2. To find out a criteria for patient selection for TURP in 
Soba University  hospital  
3. To assess and evaluate the following:- 
a. preoperative cystoscopic assessment of the prostate 
gland. 
b. Types of Anesthesia in TURP 
c. Indication of antibiotic   use.  
d. Duration of post TURP  catheterization. 
e. Hospital Stay following TURP. 
4. To identify the value of incidental finding of carcinoma of 
the prostate.   
5. To assess the post TURP complications and their impact 
on outcome.  
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MATERIALS AND METHODS 
Study design:- 
This is a retrospective hospital-based study. 
Study area: - 
This study was carried out in the Department of Urology at 
Soba University Hospital. 
Study population: - 
All the patients who underwent TURP in Soba University 
Hospital in the period from January 1999 to December 2002 were 
included. 
Exclusion Criteria:- 
Patients with incomplete records were excluded from this 
study. 
Data collection:- 
  One hundred and seven patients who underwent TURP within 
the last 5 years (January 1999 to December 2003) were studied.  The 
records of one hundred patients were available for this study. Their 
records (genitourinary cards and files) have been checked and 
transferred to the questionnaire attached. 
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Seven patients were excluded because of incomplete records. 
Data analysis:- 
The data collected was introduced in a computer system and 
analyzed using the statistical package for social science (SPSS), 
accordingly tables and diagrams were formed and results obtained.  
Using manual techniques the frequency of the variables were 
arranged in tables and diagrams and results were obtained.      
Research tools:- 
 A questionnaire addressing the crucial points was utilized to 
obtain the necessary information. (The questionnaire is attached at 
the appendix).      
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Chapter Three 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
 
 One hundred male patients, who underwent transurethral 
resection of the prostate (TURP) in Soba university hospital were 
included in this study, in the period from January 1999 to December 
2003. 
 In 97 patients (97%) TURP was performed for benign prostatic 
hyperplasia, while it was performed for Ca prostate in three patients, 
as relief for obstructive symptoms.  
 Their ages ranged between 50 and 86 with a mean age of 66.7 
years. The majority of the patients 70 (70%) were between 61and 80 
years of age, 8 patients (8%) were over 80 years (Fig 1). 
 The majority of the patients 85 (85%) were from the central 
parts of the Sudan, 15 patients (15%) from other parts of the Sudan. 
(Fig 2) 
Thirty two patients (32%) were farmers, and 37 (37%) were 
retired . (Fig 3) 
Ninety nine patients were married (99%). (Fig 4) 
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Presenting symptoms:- 
 The duration of the presenting symptoms varied from one week 
to 20 years, with a mean duration of symptoms of 2.3 years.   
The duration of symptoms was more than one year in 60 
patients (60%), and  less than one year in 40 patients (40%).(Table 1). 
Ninety eight patients (98%) presented with combination of irritative 
and obstructive symptoms, while irritative symptoms dominated in the 
remaining group (Fig 5).  Increased Frequency was  the most 
common irritative symptom. It was one of the main  presenting 
symptom in 88 patient (88%), followed by dysuria which was one of 
the presenting symptoms in 86 patients (86%) ( Table 2). 
The most common obstructive symptoms was weak stream of 
urine, it was one of the presenting symptoms in 70 patients (71.4%) 
(Table 3). 
Forty patients (40%) presented with urine retention, 19 patients 
(19%) with haematuria. The least presenting symptom was urine 
incontinence occurring in 3% of the patients (Fig. 5).    
Other associated diseases and past medical history: -
Twenty two patients (22%) were hypertensive while 7(7%) were 
diabetic. Three patients (3%) had renal impairment at presentation.  
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Four patients (4%) had inguinal hernia, and one patient (1%) had 
vaginal hydrocele at presentation.  
Ten patients (10%) had past history of passage of stone per 
urethra (table 4). 
 Thirteen patients gave past history of prostatectomy, 8 (8%) of 
them were open prostatectomy, and 5 (5%) were TURP.  
Two patients (2%) had past history of DVIU (table 5). 
Digital rectal examination (DRE):- 
 The findings of DRE were reported in 84 patients (84%). The 
size of the prostate was estimated as being less than 40 g in 62 
patients (73.8%), between 40-60 g in 10 patients (11.9%), and more 
than 60gm in 2 patients (Fig 6).The largest size of the prostate 
estimated was 100g.  
The prostate was benign feeling in 81 patients (96.4), malignant 
in one patient (1.2), and not reported in 2 patients (2.38%) (Table 6). 
Investigations:- 
The hemoglobin was less than 9gm in 4 patients (4%), and 
more than 9gm in 96 patients (96%) (Table 7). 
The findings of urine analysis were reported in 97 (97%).  The 
urine was found to be infected in 50 patients (51.5%) (Fig 7).       
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The level of the blood urea was reported in 99 patients (99%). 
Fifteen (14.85%) were found to had blood urea more than 50 mg/dl 
(Fig 8). 
Ultrasonography:- Abdominal U/S was performed in 70 patients 
(70%)  (Fig 9).  In 42 patients (60%), the prostate was reported to 
have mild enlargement, moderate in 16 patients (22.9) and huge 
enlargement in 3 patients (4.3%) (Table 8). 
Preoperative urethrocystoscopy:- Urethrocystoscopy was 
performed in 62 (62%).  It showed mild enlargement of the prostate in 
47 patients (75.8%), moderate enlargement in 9 patients (14.5%), 
while huge enlargement in 5 patients (8.1%) (Fig 10).  
    The median lobe of the prostate was the main component of 
enlargement in 30 patients (48.3%), the lateral lobe in 6 patients 
(9.6%), while there was trilobar enlargement in 13 patients (20.9%), 
and it was not specified in 13 patients (20.9%) (Table 9). 
Urinary bladder findings at cyctoscopy:- The most common 
finding was trabiculations, occurring in 26 patients (41.9%). 
Bladder stones were found in 11 patients (17.7%) (Table 10). 
Prostate specific antigen (PSA):- PSA was performed in for 40 
patients (40%).  In twenty one patients (52.5%) the PSA level   was 
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below 4 ng/L, in  10 patients (25%) it was between 4 and 10 ng/L, in  
7 patients (17.5%) between 10 to 20, while in 2 patients ( 5%) it was  
more than 20 ng/L ( Fig 11). 
Transrectal biopsy:- Was done for 11 patients (11%) (Fig 12). In 
three patients it showed carcinoma of the prostate (27.3%), while in 8 
it showed BPH (Fig 13). 
Indications of TURP:- 
The most common indications for TURP were lower urinary 
tract symptoms (LUTS). One hundred patients (100%) presented with 
irritative symptoms, while 98 presented with obstructive symptoms 
(98%) (Fig 5). 
TURP was indicated for LUTS alone in 37 patients (37%), while 
in 63 (63%) there were combinations of LUTS with other indications 
(Fig 14). 
The most common indications in combination with LUTS were 
urine retention in 40 patients (40%), haematuria in 19 patients (19%) 
recurrent UTI in 13 patients (13%), and bladder stone in 11 patients 
(11%) (Table 11).  
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Types of Anesthesia for TURP:- 
The commonest type of anaesthesia was spinal given in 83 
patients (83%), epidural in 9 patients (9%) while general in 8 
patients (8%)  (Table 12). 
There were no complications reported from anesthesia.  
Prophylactic antibiotics in form of gentamycin or cephalexin were 
given for all patients with induction of the anesthesia. 
The Procedure for TURP:- 
 All the TURPs were performed using resectoscope size 24F- 
(STor2).  The urethra was calibrated as routine up to size 26F; the 
TURP was performed using distilled water with continuous irrigation 
in most of the patients.    
A size 20 or 22 F 3 ways Foley catheter was left indwelling 
for 2 to 4 days with irrigation in the first few hours of post-TURP 
period. 
Associated peroperative procedures:- 
 Additional peroperative procedures were performed in 20 
patients (20%); the most common was cystolitholapaxy in 9 
patients (39.13%) and   urethral dilatation in 6 patients (Table 13). 
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Mortality:-  
There were no intraoperative or postoperative deaths 
reported due to TURP within the period of the study. 
Complications:- 
Five patients (5%) developed intraoperative bleeding, 3 of them 
required a blood transfusion (3%) (Fig 15).  
Early  postoperative complications: 
The total number of early postoperative complications was13 
(13%). The most common early post operative complication was UTI, 
seen in 5 patients (5%), followed by urine  retention in 3 patients (3%), 
then incontinence in 2 patients (2%) while TUR  syndrome  occurred 
in only 1 patient (1%) (Table 14).      
Late complications:- 
Late complications were detected in patients who came for 
follow-up at least 6 weeks postoperatively. 
Sixty two patients (62%) could be followed-up in arrange of 6 
weeks to 3.5 years.  Out of these 62 patients, 8 (12.9%) presented 
with irritative symptoms. Urethral stricture occurred in 4 patients 
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(6.45%), recurrence of obstructive symptoms in 4 patients (6.45%) 
and haematuria in 4 patients (6.45%). The total number of patients   
who developed late postoperative complications was 21 patients 
(33.9%). Fifteen out of these 21 patients showed improvement during 
the period of the follow-up (Table 15).     
Hospital stay and duration of catheterization:-  
The mean postoperative duration of catheterization was (3.3) 
days.  In 59 patients (59%) the catheter was removed within the first 
two postoperative days.  In 34 patients (34%) it was removed 
between 3 to 5 days, while in 7 (7%) patients the catheter was 
removed after the   5th day. In all patients with prolonged period of 
catheterization the hospital stay was also prolonged (Table 16). 
The mean hospital stay was 5.7 days. Twenty four patients 
(24%) were discharged within the first 3 postoperative days.  Fifty six 
(56%) were discharged  between 4 to 6 days, while in twenty patients 
(20%) the hospital stay was   more than six days ( Table 17).          
 The histopathological findings:- 
Figure sixteen shows the result of histopathology in 78  patients  
representing (78%) of the  total sample.  In eight  patients (10.3%)  
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the  histology showed carcinoma of  the prostate, while in seventy  
patients (89.7%) it showed benign prostatic hyperplasia (Fig 16).  
Incidental finding of ca prostate was reported in five patients 
(7%).  
Treatment of post TURP complications:- 
Four patients (4%) required blood transfusion and 6 patients 
(6%) required antibiotic therapy, one of them for bactreamia and the 
other five for UTI.  One patient (1%) who developed TUR syndrome 
admitted to ICU and treated conservatively. Two patients with clot 
retention, has clot evacuation using Elik. Four patients with post 
TURP urethral stricture required DVIU. 
One patient with urine retention due to residual prostatic tissue 
required revision of TURP.            
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Table 1: Duration of symptoms 
 
 
 
 Number Percent
Less than one month 7 7.0
  One  moth to one year 33 33.0
More than one year 60 60.0
Total 100 100.0
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Table 2: Frequency of Irritative symptoms in 100 patients 
 
 
 
Number Percent
Increased Frequency 88 88.0
Dysuria 86 86.0
Urgency 63 63.0
Urge incontinence 31 31.0
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Table 3: Frequency of Obstructive symptoms in 98 patients  
 
 
 
 
Number Percent
Weak stream 70 71.4
Dribbling 57 58.1
Hesitancy 55 56.1
Intermittency 12 12.2
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Table 4: past history and  associated diseases in 100 patients 
 
 
Number Percent
Hypertension 22 22.0
Belharziasis 17 17.0
passage of stones per 
urethra
10 10.0
Diabetes mellitus 7 7.0
Inguinal hernia 4 4
renal impairment 3 3.0
STD 2 2.0
Hydrocele 1 1.0
Varicocele 1 1.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
49 
 
 
 
 
Table 5: past history of surgical procedures in 100 patients 
 
 
 
 
Number Percent
prostatectomy (open) 8 8.0
prostatectomy (TURP) 5 5.0
DVIU 2 2.0
Nephrectomy 1 1.0
Pyelolithotomy 1 1.0
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Table 6: feeling of the prostate on DRE (digital rectal examination) in 
84 patients 
 
 
 
 
Number Percent
Benign 81 96.4
Malignant 1 1.2
Not reported 2 2.4
Total 84 100.0
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Table 7: Hemoglobin level 
 
 
 Number Percent
<9 gm 4 4.0
9-12 gm 47 47.0
>12 gm 49 49.0
Total 100 100.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 
Table 8: Prostate size on abdominal U/S in  70 patients 
 
 
 
Number Percent
mild enlargement 42 60.0
moderate enlargement 16 22.9
huge enlargement 3 4.3
not reported 5 7.1
Normal 4 5.7
Total 70 100.0
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Table 9: Lobes affected on preoperative cystoscopy in 62 patients 
 
 
 
Number Percent
Median 30 48.38
Lateral 6 9.68
Both 13 20.97
not reported 13 20.97
Total 62 100.0
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Table 10: Urinary bladder findings at cystoscopy  in 62 patients 
 
 
 Number Percent
Normal 29 46.8
Trabiculations 26 41.9
Saculations 6 9.7
Diverticulation 9 14.5
vesical stone 11 17.7
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Table 11: frequency of other indications in combination  
                 with LUTS in 100 patients  
 
 
Indications number percent
Urine retention 40 40%
Haematuria  19 19%
recurrent UTI 13 13%
Bladder stone 11 11%
Renal impairment 3 3%
Adenocarcinoma 3 3%
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Table 12:  Type of anesthesia 
 
 
Number Percent
Spinal 83 83.0
Epidural 9 9.0
General 8 8.0
Total 100 100.0
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Table 13: Associated peroperative procedures done in 20 patients 
 
 
 
Number Percent
 Urethral dilatation 6 26.1
DVIU 4 17.4
Cystolitholapaxy 9 39.1
BNI 2 8.7
TURBT 1 4.4
vesicolithotomy 1 4.4
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Table 14: early  postoperative complications in 100 patients 
 
 
 
Number Percent
bleeding (required transfusion) 1 1.0
TUR syndrome 1 1.0
urine incontenence 2 2.0
urine retention 3 3.0
Infection 6 6.0
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Table 15: Late Postoperative complications in 62 patients  
 
 
 
 
 Number percent No. of pts. improved 
Irritative symptoms 8 12.9 6
Urethral stricture 4 6.45 4
Recurrent obstructive 
symptoms
4 6.45 2
Haematuria 4 6.45 2
Pain after micturition 1 1.61 1
Total 21 33.9 15
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Table 16: Duration of catheterization 
 
 
 
Number Percent
Up to 2 days 59 59.0
3-5 days 34 34.0
>5 days 7 7.0
Total 100 100.0
Mean 3.29 days
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Table 17: Hospital stay 
 
 
 
 Number Percent
<4 days 24 24.0
4-6 days 56 56.0
>6 days 20 20.0
Total 100 100.0
Mean   5.75 days 
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Figure 1: Age distribution in years
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Figure 6: Prostate size on DRE
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Figure 10: Preoperative diagnostic cystoscopy and description of prostatic size
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Figure 11: The level of  PSA in (40 patients)
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Figure 12: Trans-rectal prostatic biopsy
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Figure 15: Intraoperative complications in 100 patients
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Figure 16 : Histopathology findings
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Chapter Four  
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
In this study the age distribution was between 50 and 86 with a 
mean age of 66.7 years. The majority of the patients being in 61-80 
age groups.  Cetinel et al (1994) in Istambul University evaluated 96 
patients with BPH.  The mean age was 63.4 years and the most 
common age was in 60-79 years age group (21). 
Mebust et al (1989) in a study including a series of 3885 
patients in intraoperative and immediate postoperative complications 
of TURP. They found that most of the patients being in (60–79) age 
group(35).  Kambal (1977) in a local study in prostatic obstruction in 
the Sudan reported a mean age of 66.7 years (36).  
The above mentioned findings are consistent with age 
distribution in the present study. 
Most of the patients were from central parts of the Sudan where 
access to Soba University Hospital is easy and most of the people 
can afford the cost of the operation.  
In this study the duration of symptoms ranged from one week to 
20 years with a mean of 2.3 years. This may reflect negligence of  
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some patients to their symptoms for long periods and ignorance 
of others to the nature of the disease. 
In this study, irritative and obstructive symptoms were 
dominated while urine retention was the presenting symptoms in 40% 
of the patients. Kambal (1977) found that more than 80% of his 
patients presented with urine retention while 17.1% presented with 
other symptoms(36). 
 The change in the prevalence of the symptoms may be due to 
advancement of diagnostic tools which can pick up the problem early, 
help in the evaluation of the condition and selection of suitable type of 
treatment.  All these can lead to reduction in the complications of 
BPH.  Bruskewitz et al (1986) and Mebust et al (1989) reported that 
the irritative and obstructive symptoms were predominant while urine 
retention represent 4% an27% of their patients respectively(22,35).  
This is in agreement with the findings of the study.  
The review of the medical history in this study revealed that the 
most common associated medical problem was hypertension. Twenty 
two percent of the patients were hypertensive while 7% were diabetic 
and 3% had renal impairment at presentation.  
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Arther et al (1995) reported hypertension as a common medical 
problem in 412 patients coming for TURP, cardiopulmonary disease 
as second while diabetes as third (37). 
Mebust et al (1989) in the cooperative study in post TURP 
complications showed the most common medical problems as 
pulmonary problems noted in 14.5% of his patients. Hypertension 
was the principal condition among 43% of unclassified medical 
problems. Diabetics noted in (9.8%) of the patients and renal 
insufficiency in (9.8%)(35).  
 In this study (13%) of the patients had past history of 
prostatectomy. Eight percent had open and 5% TURP. The time 
lapsed between the first operation and symptoms recurrence ranged 
between (6-14) years for open prostatectomy and 8 month to 5 years 
for TURP.  In comparison: Mutest et al (1989) reported similar results 
in his cooperative study in post TURP complications. He reported a 
prior transurethral prostatectomy in (13.3 %) of his patients(35).    
In this study inguinal hernia was an associated problem in 4% 
of the patients.  Hernia repair was done 3 to 4 months after TURP. 
Agrawal and Kumar (1993) in a study including 83 patients reported 
inguinal hernia repair simultaneously with TURP in four patients(38).  
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Devarjan et al (1999) studied 85 patients who underwent 
combined TURP and hernia repair.  He found that the recurrence rate 
of hernia was 2% and he concluded that: in an experienced hand 
performing primary hernia repair with TURP is acceptable and has a 
low complication rate. It is advantageous to the patients in having to 
under go only one anaesthetic procedure, hospital admission and 
convalescence beside an effective use of resources(39).  
In this study the size of the prostate was estimated by using 
DRE, U/S and cystoscopy.  In 84 patients the size of the prostate as 
estimated by DRE was less than 40 gm in most of the patients 
(73.8%).  The maximum estimated size was 100 gm.  
Young et al (1999) in his survey questionnaire sent to 376 
consultant urologist about treatment of benign prostatic obstruction 
BPO in the UK. Sixty percent of the respondents used the prostate 
size as a determinant when deciding on therapy for BPO. The most 
common procedure used was TURP in 79% of patients. The 
minimum size considered for TURP was 27 ml, and the maximum 
one was 107ml. Of the methods used to assess the size of the 
prostate, 86% of surgeons used cystoscopy and 9% used cystoscopy 
plus TRUS. In the same study he stated that: the DRE plus 
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cystoscopy (once the decision to use a surgical treatment has been 
made) will remain the principle methods of assessing prostate size (40). 
In the present study preoperative haemoglobin was done for all 
patients. It was less than 9 gm in 4 patients (4%).  Two of these 
patients had renal insufficiency.   All these 4 patients were transfused 
preoperatively. Also in this study the incidence of urinary tract 
infection with BPH was reported as 51.5%.      
In comparison to a local study done by Kambal (1978), 32.6% 
out of 367 patients were transfused preoperatively because their 
hemoglobin was less than 10g. In the same study Kambal found that 
the incidence of urinary tract infection with BPH was 91.7 %( 41). 
The current decrease in the incidence of urinary tract infection 
with BPH may be due to the presence of facilities for early diagnosis, 
improvement in methods of culture and sensitivity and the 
introduction of new generations of antibiotics. 
Abdominal ultrasound and cystoscopy were used in this study 
at first for diagnosis then for estimation of the size of the prostate, 
detection of the lobe affected and looking for abnormal bladder 
findings. Cystoscopy was performed for 62 patients (62%). The most 
commonly affected lobe was the median lobe detected in (48.3%) of 
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the patients.  Abnormal bladder findings were detected in (53.2%) 
and bladder stones were found in eleven patients (17.7%). 
Kambal (1978) reported bladder stones were found in 52 
patients as associated problem with BPH(41). 
BPH appears to predispose to bladder stones as stated by 
Grosse (1990).  He found that bladder stones were about eight 
times more frequent in the men with histological evidence of BPH 
at autopsy (42). 
In this study history, digital rectal examination (DRE), PSA level 
and transrectal biopsy were used for defection of carcinoma of the 
prostate.  Carcinoma of the prostate was detected in 3 patients (3%). 
Holtgrewe (1962) in a study including a series of 2015 patients 
reported carcinoma of the prostate as15% of his cases (43). 
Mubset et al 1989 reported an incidence of 10% of clinically 
apparent ca prostate(35). 
Kirby et al (1994) screened 568 patients aged 55 to 70 years for 
prostate cancer using DRE, PSA level, TRUS and transrectal biopsy. 
Prostate cancer was confirmed in 11 patients giving an overall 
detected prevalence of 2%(44). 
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In this study the most common indications for TURP were LUTS. 
Ninety eight percent of the patients came with combination of both  
irritative and obstructive symptoms. Other indications in combination 
with LUTS were urine retention occurring in 40% of patients, 
hematuria in 19%, recurrent UTI in (13%), vesicle stone in 11%, urine 
incontinence in (3%), adenocarcinoma of the prostate with severe 
obstructive symptoms in (3%) and   renal impairment in (3%). 
Mubest et al In his cooperative study of 13 institutions in 3885 
patients published in (1989) reported that: The most common 
indication for TURP was symptoms of prostatism (LUTS), occurring in 
91% of patients (he defined prostatism as patients with bladder out let 
obstructive symptoms, for example decrease in force and caliber of 
urinary stream, and bladder hyperflexia, for example urinary urgency, 
frequency, and nucturia). In the same study (70%) of the patients had 
more than one indications for TURP. Other indications reported in 
combination with symptoms of prostatism, or alone were significant 
residual urine in (34.4%) of the patients, urinary retention in (27%), 
recurrent UTI in (12%), haematuria in (12%), altered urodynamic 
functions in (9.9%), renal insufficiency in (4.5%) and bladder stone in 
(3%)(35). 
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Diabetic and hypertensive patients were evaluated and 
controlled preoperatively.  Four patients were transfused.  In this 
study TURP was done under spinal or epidural anesthesia in (92%) 
patients and general anesthesia in (8%). All patients received 
prophylactic antibiotic with induction of anesthesia and no anesthetic 
complications were reported. 
Horninger et al (1996) in study on mortality and morbidity of 
TURP including 1211patients reported that (91.1%) of all patients 
were operated under spinal anesthesia, while in (8.9%) general 
anesthesia were used.  All patients received prophylactic antibiotic(45). 
Spinal or epidural anesthesia was used in (79%) of all TURP. This 
result was reported in a national survey study (in USA) done by 
Holttgrewe et al in (1989). The study including 2716 consultant 
urologists who responded to the questionnaire conducted(46).  
Mubest et al (1989) in his cooperative study reported that (78%) 
of TURPs were done under spinal or epidural anaesthesia(35). 
McGowan and Smith (1980) found, no significant difference 
between regional and general anaesthesia for TURP, in term of 
complications blood loss and preoperative mortality (31).    
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In this study all the procedures were performed by two expert 
consultant urologists. Post TURP irrigant used was distilled water 
with continuous irrigation in most of the patients with very low 
incidences of complications. TUR syndrome was reported in only one 
patient (1%).  
The safety of distilled water for TURP has been evaluated by      
Shin et al (1991) at department of anesthesiology in Veteran’s 
General Hospital in China. He studied 53 patients, who underwent 
TURP using distilled water for irrigation with continues drainage.  His 
results showed evidence of fluid absorption, but there was no TUR 
syndrome reported in his patients. He concluded that: distilled water 
is relatively safe irrigant fluid for TURP(28).   
This is also in accordance to the study done by Memon et al 
(1999) in Pakistan. He evaluated safety of distilled water as an 
irrigant for TURP, and as a cost–effective alternative. His study 
included 60 patients.  No TUR syndrome has been reported within his 
patients.  He concluded that: Distilled water is a safe irrigant fluid for 
TURP even with some degree of absorption.  Saving for the patient is 
considerable and this renders the treatment affordable (27).  Also the 
use of modern irrigation fluids (glycine1.5%) in TURP is a great 
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contributor in lowering the incidence of TUR syndrome. This has 
been reported by Madersbacher and Marberger (1999) in a study in 
justification of TURP. They analyzed 29 randomized clinical trial 
studies (RCTs). The TUR syndrome was reported only in three 
studies, at 3.4%, 4.7 % and 6.7%. They stated that TUR syndrome 
has largely disappeared through the use of modern irrigation fluids, 
improved surgical technique and instrumentation(47).  
In this study, additional peroperative procedures were 
performed in 20% of the patients. The common one was 
cystolitholapaxy done in 9% the patients followed by urethral 
dilatation, then DVIU.  Agrawal and Kumar (1993) reported an 
incidence of 12% out of 83 patients who underwent a simultaneous 
procedure with TURP. The procedures were cystolitholapaxy, 
inguinal Hernia, or epididymal cyst(38). 
The mortality rate reported in this study was 00.0%. Holtgrewe 
and Valks (1962) reported a mortality rate of 2.5%(43). 
Mubest et al (1989) in a large multicenter study   on a series of 
3885 patients reported a mortality rate of 0.23.  They concluded that 
the mortality has been reduced for transurethral prostatectomy from 
2.5 to 0.2 percent during the last 27 years (35). 
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Thrope et al (1996) reported a post TURP mortality rate of 0.9% 
out of 1396 patients(48). 
Mortality and morbidity of TURP were studied by Horninger et al 
(1996) in a retrospective study in total of 1211 patients. They reported 
a mortality rate of 00.0%(45).   
In the present study the rate of intraoperative complications was 
5%. The only reported intraoperative complication was bleeding 
occurred in 5 patients (5%).  Blood transfusion was required for only 
3% of the patients.  No TUR syndrome or perforation was reported 
intraoperatively.  In comparison to some other studies: Mubest (1989) 
reported a rate of intraoperative complications of 6.9%. The most 
common intraoperative complications were bleeding requiring 
transfusion in 2.5% of his patients, TUR syndrome in 2%, myocardial 
arrythmia in 1.1% and extravasaion in 0.9%(35). 
Hroninger et al (1996) reported intraoperative complication rate 
of 8.9%.  Bleeding was the most common complication noted in 4.2% 
of the patients followed by TUR syndrome in 2.8%, cardiovascular 
problems in 1% and bladder perforation in 0.9%(45). 
The rate of early postoperative complications in this study was 
13%. The most common early post TURP complication was UTI 
 
 
89 
occurring in 5% of the patients, followed by urine retention in 3 
patients (3%).  One of the three patients who presented   with urine 
incontinence preoperatively regained his urine control completely 
post TURP.  The other 2 patients (2%) continued to be incontinent 
and discharged with condom catheter.  TUR syndrome observed in 
one patient (1%). 
 Holtgrewe and Valk (1962) published a study on post TURP 
complications in 2015 patients. They reported a morbidity rate of 18%. 
The most common early postoperative complications were 
epididymitis which was observed in 6% of the patients, repeat 
resection in 3.4%, extravasations in 1.1%, pneumonia in 1.3% and 
fluid absorption toxicity in 0.41%(43). 
Mubest et al (1989) reported post TURP complication rate of 
18%. The most common early postoperative complications were 
failure to void urine  observed in 6.5% of the patients, bleeding 
requiring transfusion in 3.9% clot retention in 3.3% and UTI in 
2.3%(35). 
Horninger et al (1996) reported a rate of early postoperative 
complications of 15.8%. The most common early postoperative 
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complications were urinary retention observed in 7.5%, postoperative 
bleeding in 3.4% and urinary tract infection 2.4%(45). 
Baoum (1997) in a local study including 54 patients reported   
an early  postoperative  complications as  bacteriuria in (20.4%) of 
the patients, clot retention in 9.25, epididmorchitis in 5.5%, chest 
infection in 1.8% and incontinence in 3.7%(7). 
Carter et al (1999) reported post TURP complications in a 
group of 96 patients. The most common early postoperative 
complications were bleeding requiring transfusion in (5%), UTI in (5%) 
and acute retention in (2%)(49). 
In the present study infection was the most common early 
postoperative complication occurring in 6 patients (6%).  
The role of using prophylactic antibiotics to reduce the 
incidence of post TURP infection is still a matter of controversy while 
Scholz (1998) et al and Nielsen et al (1981) reported the beneficial 
effect of prophylactic antibiotic in reducing the incidence of 
postoperative infection, Gibbons et al (1978 ) and Holl and Rous 
(1982) did not observe any benefits from prophylactic antibiotic in 
TURP(50,51,52,53). 
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Mubest et al (1989) reported death of septicaemia in 5 of his 
patients.  Antibiotics were started preoperatively and continued post 
operatively for 11% of his patients because of evidence of 
preoperative UTI. Prophylactic antibiotics were given for 61% of his 
patients(35). 
Horninger and his colleagues used to perform TURP under two 
preconditions only: first the urine culture must be sterile, and second 
prophylactic antibiotic were administered at least until the indwelling 
catheter was removed.  They considered this as one of the crucial 
factors contributing to the reduction in the incidence of postoperative 
septicemia.  In their study (1996) no case of septicemia was 
reported(45). 
In this study clot retention was the common early postoperative 
complication occurring in 2 patients 2%.  Both of them developed clot 
retention after stoppage of post TURP irrigation. 
Olapade et al (1998) reported clot retention in six percent of his 
patients. He concluded that; in most men who undergone TURP, 
gross heamaturia ceased within 3 weeks and clot retention usually 
occurs within 2 weeks after surgery.  So he recommended high water 
intake at least for the first 3 weeks post TURP(54). 
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Agrawal and Kumar (1993) studied 83 patients for early 
catheter removal following TURP. Five percent of their patients 
required recatheterization for one day more because of clot 
retention(38).  
In the present study late complications were detected in 62 
patients (62%). At follow-up 8 patients (12.9%) presented with 
irritative symptoms, urethral stricture occurred in (6.45%), recurrence 
of obstructive symptoms in 4 patients (6.45%) and pain after 
micturation in one patient (1.61%).  Fifteen (71%)out of these 21 
patients who developed late post TURP complications showed 
improvement during follow-up. Sexual dysfunctions can not be 
determined in this study, since they were not mentioned in the 
postoperative follow-up records.  
In the literature little has been reported concerning long term 
follow-up and late post TURP complications. 
Bruskwits et al in (1986) studied a series of 60 patients to 
evaluate the late complications.  He observed urethral stricture in 5% 
of the  patients and some degree of urge incontinence in 18%.  Of the 
sixty patients how were evaluated 3 years postoperatively, 3 patients 
noticed persistent pain following the procedure, another 3 patients 
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were treated for voiding difficulties during follow-up and one patient 
had an unexplained episodes of haematuria(22).  In comparison to the 
present study,  Bruskuitz reported similar results.  
In a local study late post TURP complications reported were 
urethral stricture in 5.5% of the patients, bladder neck contracture in 
1.8% and erectile dysfunction  in 13% (Baoum 1997)(7).  
Horninger et al (1996) reported a rate of late TURP 
complications of 11.2%. The most common postoperative 
complication was UTI observed in 3.4% of the patients, urethral 
stricture in (3.7%), bladder neck contracture in 1.9% and late 
postoperative bleeding in (1.7%)(45). 
In this study urethral stricture was one of the common late 
postoperative complications with occurrence rate of (6.45%), in a 
range of 2 to 8 months after TURP.  
In 1977 a study performed by Lentz et al yielded a rate of 
urethral stricture of (6.3%) at 4-5 months after TURP(55).   
A twenty nine randomized clinical trial (RCTs) published 
between 1986 and 1998 were analyzed by Medersbacher and 
Marberger in 1999 in a study in justification of TURP. They found that 
 
 
94 
urethral stricture was one of the major late postoperative 
complications occurred in a range of 0 -11% with a mean of (3.8%)(47).  
A rate of post TURP urethral stricture of 9% in a recent study 
including 96 patients was reported by Carter et al (1999)(49). 
In this study in59% of the patients the catheter was removed 
within the first 2 postoperative days.  The mean duration of post 
TURP catheterization was 3.2 days. Eighty percent of the patients 
were discharged within the first 6 postoperative days. The mean 
duration of hospital stay was 5.7 days.  All the patients with 
immediate postoperative complications had prolonged hospital stay.  
Mubest et al (1989) showed that the catheter was removed by 
the third postoperative day in 82 percent of the patients and 78 
percent were discharged from hospital by day 5(35). 
In a local study post TURP hospital stay ranged between 3 to 6 
days with an average of 4.2 days (Baoum 1997)(7). 
Post TURP early catheter removal and its impact on length of 
hospital stay were studied by KOH et al (1994).  He concluded that: 
removal of the catheter on the first day following TURP is safe in 
selected patients and leads to shorter postoperative hospital stay(33). 
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This is also is in accordance with the study done by Dood et al (1995) 
who studied early catheter removal following TURP in 100 
consecutive patients. He found that the hospital stay was significantly 
shortened in patients with early catheter removal. He concluded that; 
brief catheter drainage after TURP is safe and allows an earlier 
discharge from the hospital than standard duration of 
catheterization(56). 
Histopathology results were available in 75 patients. Incidental 
finding of ca prostate was reported in 5 patients in a rate of (7%).  A 
preoperative PSA level was measured in five patients and it was 
elevated in four. Transrectal biopsy was taken for 3 patients.  The 
histopathology results were benign in all of them.   In comparison to 
other studies; Horninger et al (1996) reported incidental finding of ca 
prostate in (7.5%) of the patients(45). 
Alfred et al (1982) reported an incidence of incidental ca 
prostate of 14% in 500 specimen(57). 
David et al (1992) found incidental ca prostate in a significant 
number of TURP specimens (10%)(32).              
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Conclusion 
• Transurethral Resection Of the Prostate (TURP) 
         remains the golden procedure for the effective 
          treatment of BPH.  
• This study showed that it was accompanied with very low 
morbidity          
     and no mortality.  
• The postoperative catheterization as well as hospital stay were 
only  few days.  
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RECOMMENDATIONS 
 In the Sudan there is shortage of endourology services 
including TURP facilities. Most of the main hospitals lack facilities of 
TURP. So the following are recommended:- 
1. endourology  services including TURP facilities should be 
available in the main teaching hospitals. 
2. Training of general surgeons and registrars to practice  
endourological procedures including TURP. 
3. TURS must be introduced which may help in the accuracy of 
the diagnosis of BPH, and early detection of ca prostate. 
4. Introduction  of urodynamics in the urology units can be of great 
help. 
5. A program for health education about BPH for population in 
general and especially for men above 40 years. 
6. A system for continuous orientation and updating information in 
BPH for doctors at , primary, secondary, and tertiary health care 
levels. 
7. Further study in symptoms prevalence of BPH in the Sudan is 
needed.     
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